A possible explanation could be decreased myostatin levels in DMD-patients, which have been reported to be approximately 70% lower compared to healthy age-matched controls and that there is a significant decrease in myostatin with ageing and loss of ambulation in DMD patients—suggesting that disease progression plays a role in circulating myostatin levels [36]. The gene discussed is MSTN; the disease is Duchenne muscular dystrophy.